Destination 'lysosome': a target organelle for tumour cell killing?
about
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicineA series of naphthalimide derivatives as intra and extracellular pH sensorsLabeling and exocytosis of secretory compartments in RBL mastocytes by polystyrene and mesoporous silica nanoparticles.Impairment of lysosomal activity as a therapeutic modality targeting cancer stem cells of embryonal rhabdomyosarcoma cell line RD.The cell biology of lysosomal storage disorders.Chemotherapy drug response in ovarian cancer cells strictly depends on a cathepsin D-Bax activation loop.An Active 32-kDa Cathepsin L Is Secreted Directly from HT 1080 Fibrosarcoma Cells and Not via Lysosomal Exocytosis.Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes.Biocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups.Antiprotease therapy in cancer: hot or not?Endocytic mechanisms for targeted drug deliveryTargeted polymeric therapeutic nanoparticles: design, development and clinical translationMannose 6-phosphate receptor targeting and its applications in human diseases.Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet.Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance.Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer.Knockdown of cathepsin D in zebrafish fertilized eggs determines congenital myopathy.Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids.Differential role of cathepsins B and L in autophagy-associated cell death induced by arsenic trioxide in U87 human glioblastoma cells.Hypoxia inhibits TRAIL-induced tumor cell apoptosis: involvement of lysosomal cathepsins.Selective induction of apoptosis in MCF7 cancer-cell by targeted liposomes functionalised with mannose-6-phosphate.In vitro and in vivo anticancer activity of surface modified paclitaxel attached hydroxyapatite and titanium dioxide nanoparticles.Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells.
P2860
Q28391849-FD8D43E5-97E8-4A4A-83EB-58C4D46107B1Q34131373-30C19FC7-6671-4A0F-8888-89096729D3F6Q34273345-74768759-CAD3-4664-B919-DBBEF8AFC1D0Q35348175-1EBA730D-193F-4EE4-94B6-98B729440108Q35825859-A8E6EDC8-AB9A-40D0-AF32-46F0262DEDCCQ35831995-651B6BD6-96F6-4C3E-97AD-27A16C86BBCDQ35870565-DCCBDB48-0307-43BD-87A8-B68E9CEF2864Q35911354-5573F84C-9C15-4253-AAE1-A029545BA6BDQ36161045-1385D4E2-E1A8-42CC-8D52-13431C1A7730Q36407244-05D72340-F387-45E8-AA9E-CD16BED3676EQ36894849-4F9EBB48-2955-4C3D-93B0-2D9DFE51719AQ36934007-35F02945-40CC-4FAE-B2D6-3C7C08C7BBC1Q37066021-DEDA8208-ED94-4BEE-B256-9078AB9BAE20Q37157022-54115501-E281-4D50-965C-65D161803FA6Q37587184-1C74F1C0-DBD5-41EA-88F2-BC6FACC751CBQ37665338-E20F9E16-042E-4961-B215-5A627571B3F3Q37680157-E9A21BCC-05BA-4F43-85B1-1F994D412BB4Q39590431-73CF3147-73D5-4A23-A397-B49380028A0FQ39656658-C2DE74CB-7D52-4257-B3C7-0576AAC5E031Q39725726-E6BE3797-3087-45F7-9695-8766C58A2872Q40202626-60C48FD9-8FDD-431F-AB64-CA9524654BA9Q40494672-A069340D-D2C2-4556-BDC8-103A7428F68BQ44974607-958538FE-DC05-4B4D-8259-CF3DC392E5BAQ49189903-D5509D18-3B27-43B6-AC36-50C6EEC13EFB
P2860
Destination 'lysosome': a target organelle for tumour cell killing?
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Destination 'lysosome': a target organelle for tumour cell killing?
@ast
Destination 'lysosome': a target organelle for tumour cell killing?
@en
type
label
Destination 'lysosome': a target organelle for tumour cell killing?
@ast
Destination 'lysosome': a target organelle for tumour cell killing?
@en
prefLabel
Destination 'lysosome': a target organelle for tumour cell killing?
@ast
Destination 'lysosome': a target organelle for tumour cell killing?
@en
P2860
P356
P1476
Destination 'lysosome': a target organelle for tumour cell killing?
@en
P2093
Marina Démoz
Roberta Castino
P2860
P304
P356
10.1002/JMR.643
P50
P577
2003-09-01T00:00:00Z